What are the causes of dilated cardiomyopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Dilated Cardiomyopathy

Dilated cardiomyopathy results from genetic mutations in approximately 30-50% of cases (higher in children), with the remaining cases caused by acquired factors including alcohol, viral myocarditis, cardiotoxic drugs, arrhythmias, metabolic disorders, and autoimmune diseases. 1, 2

Genetic and Familial Causes

Genetic mutations are the single most important cause category, accounting for up to 50% of all dilated cardiomyopathy cases. 1, 2

  • Autosomal dominant inheritance is the most common pattern, typically presenting in the third decade with progressive disease 1
  • Genes affecting cytoskeletal-sarcomere connections are most frequently implicated, disrupting the mechanical link between contractile apparatus and cellular structure 1
  • TTN (titin gene) mutations represent the most common single genetic cause identified to date 3
  • LMNA gene mutations (encoding nuclear lamins) cause particularly aggressive disease with high arrhythmia risk and early need for device therapy 1

X-Linked Dilated Cardiomyopathy

  • Dystrophin gene mutations cause X-linked cardiomyopathy presenting in males during teen years to early 20s with rapid progression to heart failure or sudden death 1, 2
  • Elevated serum creatine kinase distinguishes these patients from other forms 1
  • Female carriers develop milder disease in the fifth decade with slower progression 1
  • Tafazzin gene mutations cause Barth syndrome, presenting in male infants with neutropenia, 3-methylglutaconic aciduria, and cardiolipin deficiency 1

Clinical Implications of Genetic Testing

  • Family screening reveals disease in 30% of first-degree relatives when echocardiography is performed, even in "sporadic" cases 1, 2
  • Genetic testing identifies a causative mutation in 30-40% of patients when comprehensive panels are used 1
  • Reduced penetrance is common, meaning some individuals inherit the mutation but never develop clinical disease 1

Acquired Causes

Toxic and Substance-Related

Alcohol-induced cardiomyopathy is particularly common in men aged 30-55 years with heavy drinking history 2

  • Patients frequently underreport alcohol consumption, requiring careful questioning about current and past use 2
  • Genetic susceptibility likely plays a role in determining who develops cardiomyopathy from alcohol 2
  • Cocaine and methamphetamine can cause dilated cardiomyopathy through direct cardiotoxic effects 2
  • Chemotherapeutic agents (anthracyclines, trastuzumab) are well-established causes 4, 5

Infectious and Inflammatory

Viral myocarditis accounts for up to 75% of myocardial infarction with non-obstructive coronary arteries (MINOCA) presentations and may evolve into dilated cardiomyopathy 2

  • Enteroviruses (especially Coxsackie B), adenoviruses, and parvovirus B19 are the most common viral pathogens in North America and Western Europe 6
  • Recent viral syndrome preceding heart failure symptoms suggests myocarditis, though serum antibody titers have low diagnostic yield 2
  • HIV-associated cardiomyopathy occurs in approximately 8% of asymptomatic HIV-positive individuals 2
  • HIV screening should be performed in younger patients with unexplained dilated cardiomyopathy, particularly those with risk factors 2
  • Chagas disease (Trypanosoma cruzi) causes progressive myocardial damage through parasite persistence and autoimmune responses, with 50% mortality within 4 years of heart failure onset 7

Arrhythmia-Induced Cardiomyopathy

PVC burden ≥24% is independently associated with cardiomyopathy, though the minimum threshold appears to be 10% 1, 7

  • Sustained ventricular rate ≥130 bpm during atrial fibrillation can itself induce dilated cardiomyopathy 2
  • Radiofrequency ablation normalizes ejection fraction in 82% of patients with PVC-induced cardiomyopathy within 6 months 1, 7
  • Right ventricular outflow tract is the most common PVC origin (52% of cases) 1
  • Clues that PVCs are causative include high burden (>10-15%), epicardial origin, and improvement with suppression or ablation 2
  • Tachycardia-induced cardiomyopathy was found in 6.8% of a referral heart failure population 1

Metabolic and Endocrine

Both hyperthyroidism and hypothyroidism can cause or contribute to heart failure 2, 7

  • Measure thyroid-stimulating hormone in all patients with newly diagnosed dilated cardiomyopathy 2, 7
  • Hemochromatosis screening with fasting transferrin saturation is recommended, as mutated alleles are common in Northern European descent 2, 7

Autoimmune and Rheumatologic

Systemic lupus erythematosus increases heart failure hospitalization risk 1-3 times, with highest risk in women <45 years 7

  • Three main mechanisms in SLE: atherosclerosis (2-10 fold increased MI risk), myocarditis/inflammation, and drug-induced impairments 7
  • Rheumatoid arthritis and other connective tissue disorders can cause dilated cardiomyopathy 2
  • Sarcoidosis should be considered, particularly when cardiac MRI shows characteristic patterns 2

Peripartum and Stress-Related

Peripartum cardiomyopathy presents during the last month of pregnancy or within 5 months postpartum 7

  • Risk factors include multiparity, advanced maternal age, obesity, and hypertension 7
  • Stress-induced (Takotsubo) cardiomyopathy presents with acute, usually reversible LV dysfunction triggered by emotional or physical stress, mediated by catecholamine excess 7

Neuromuscular Disorders

Myotonic dystrophy type 1 causes dilated cardiomyopathy in approximately 80% of patients, with cardiac manifestations being a leading cause of death 7

  • DM1 results from CTG trinucleotide repeat expansion in the DMPK gene, with longer repeats correlating with earlier onset and more severe disease 7
  • Cardiac involvement is particularly high-risk in younger patients aged 2-30 years, manifesting primarily as progressive conduction defects and tachyarrhythmias 7

Critical Diagnostic Pitfalls

Approximately half of patients with heart failure and reduced ejection fraction have normal or near-normal coronary arteries, underscoring the prevalence of non-ischemic mechanisms 2

  • Non-ischemic cardiomyopathy can produce perfusion deficits and regional wall-motion abnormalities that mimic ischemic heart disease on non-invasive testing 2
  • A 3-generation family history is essential when assessing cardiomyopathy causes, as genetic mutations account for 30-50% of cases 7
  • Cardiac MRI should be considered at least once in every dilated cardiomyopathy patient for tissue characterization (fibrosis, edema, infiltration) to suggest underlying cause 2, 7
  • Routine endomyocardial biopsy is not recommended for initial work-up because histology typically shows nonspecific findings that do not guide management 2
  • Biopsy may be reserved for cases where a specific, treatable condition is strongly suspected based on other clinical data (e.g., infiltrative disease, sarcoidosis) 2

Heterogeneity and Evolution

Some diseases do not have uniformly static expression but evolve from one category to another during their natural clinical course 1

  • Patients with ARVC, hypertrophic cardiomyopathy, and LVNC can subsequently develop dilated ventricles through remodeling 1
  • 5-15% of patients with acquired dilated cardiomyopathy harbor a likely pathogenic gene variant, requiring consideration of both genetic and acquired factors in every case 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Causes and Diagnostic Approach to Dilated Cardiomyopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Genetic basis of dilated cardiomyopathy.

International journal of cardiology, 2016

Research

Dilated Cardiomyopathy - Exploring the Underlying Causes.

Medical research archives, 2024

Guideline

Myocarditis in Adolescents: Causes, Diagnosis, and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Unusual Causes of Dilated Cardiomyopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.